Quiet Therapeutics quietx.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Quiet Therapeutics, founded in 2010 is developing novel siRNA delivery solutions. Its proprietary GAGomer nanoparticles are unique in their ability to deliver nucleic acids based on the recognition of a validated marker expressed by cancer cells.

Quiet Therapeutics, founded in 2010 is developing novel siRNA delivery solutions. Its proprietary GAGomer nanoparticles are unique in their ability to deliver nucleic acids based on the recognition of a validated marker expressed by cancer cells.

Company (Alive / Active)

All investors data 2 Investors

Phone: 972-74-703-3631

Fax:

7 Pinchas Sapi
5th Floor
 Ness Ziona, 74140
 Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Quiet Therapeutics $5.5M Jan 15, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Quiet Therapeutics Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors

Board Members

Name Firm
Login to see detailsL Capital Partners
Login to see detailsPhysiome Sciences
Login to see detailsPontifax
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Lipidated glycosaminoglycan particles for the delivery of nucleic acids Mar 14, 2013 Mar 27, 2018 Patent